Vektor announced the development of a unified influenza and COVID-19 vaccine :: Society :: RBC

Studies have shown that the simultaneous illness of seasonal flu and coronavirus significantly increases the severity of influenza and increases the likelihood of death, said Rinat Maksyutov, general director of the center.

Photo: Evgeny Epanchintsev / RIA Novosti

Specialists of the Vector Research Center of Rospotrebnadzor are developing a combined influenza and COVID-19 vaccine. About it reported head of the center Rinat Maksyutov at a special session at the annual meeting of the Valdai International Discussion Club.

“The center is working to develop a combined vaccine against coronavirus and seasonal flu,” Maksyutov said.

According to the head of the center, Vektor conducted a comprehensive study of co-infection with the seasonal influenza virus and coronavirus. “It showed that the simultaneous illness of influenza and COVID-19 significantly increases the severity and mortality of the seasonal flu,” he said. “The relevance of these studies has not only a theoretical evidence base, but also a practical one,” added Maksyutov.

WHO pledges to draw conclusions about the “Vector” vaccine after three phases of trials

Now in Russia, two vaccines against coronavirus have been registered. The first, called “Sputnik V”, developed specialists of the National Research Center for Epidemiology and Microbiology named after N.F.Gamalei. She will be able to protect a person from coronavirus for about two years, said the head of the center, Alexander Gunzburg.


Read Also:  Emergency: What is an emergency? From when will it apply?
Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.